POLISCOPE
Back to feed
NewsCBS News PoliticsMay 4, 2026United States

Supreme Court Temporarily Keeps Abortion Pill Access via Mail

Justice Samuel Alito has issued a temporary stay that keeps current FDA rules in place, allowing the abortion pill mifepristone to be prescribed via telehealth and sent through the mail. This order pauses a lower court ruling that would have blocked these delivery methods while the Supreme Court considers the case.

abortionmifepristoneSupreme CourtFDAtelehealthreproductive rights
Read the full story at CBS News Politics

Why It Matters

The order maintains nationwide access to via mail and telehealth until at least May 11, 2026, preventing an immediate disruption in abortion medication services while the Supreme Court reviews the legal challenge from Louisiana.

Key Facts

  • Justice Samuel Alito issued an administrative stay pausing a 5th Circuit Court of Appeals order that would have blocked the mailing of mifepristone.
  • The stay remains in effect until 5 p.m. on May 11, 2026.
  • The Supreme Court is currently considering emergency appeals from drug manufacturers Danco Laboratories and GenBioPro.
  • Louisiana officials have until Thursday to respond to the drugmakers' emergency appeals.
  • The 5th Circuit Court of Appeals had previously ruled that Louisiana has legal standing to sue because its Medicaid program covered emergency care for women experiencing complications from the drug.
  • The FDA formally authorized the prescription of mifepristone via telehealth and delivery by mail in 2023.
  • In 2024, the Supreme Court unanimously rejected a separate challenge to mifepristone access on the grounds that the plaintiffs lacked legal standing.
  • Louisiana law currently designates mifepristone and misoprostol as controlled substances and criminalizes possession without a prescription.

Who's Mentioned

personSamuel Alito“Supreme Court Justice who issued the administrative stay.”organizationU.S. Court of Appeals for the 5th Circuit“Court that initially blocked the FDA's mail-order rule.”organizationDanco Laboratories“Manufacturer of mifepristone seeking emergency relief.”organizationGenBioPro“Manufacturer of generic mifepristone seeking emergency relief.”organizationFood and Drug Administration“Federal agency that approved mifepristone and the 2023 mail-order rule.”locationLouisiana“State challenging the FDA's mail-order rule for abortion pills.”